Stemgen Stock Performance
| SGNI Stock | USD 0.10 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and StemGen are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days StemGen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, StemGen is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Begin Period Cash Flow | 236.00 | |
| Total Cashflows From Investing Activities | 22.5 K |
StemGen |
StemGen Relative Risk vs. Return Landscape
If you would invest 10.00 in StemGen on October 28, 2025 and sell it today you would earn a total of 0.00 from holding StemGen or generate 0.0% return on investment over 90 days. StemGen is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than StemGen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
StemGen Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of StemGen for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for StemGen can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| StemGen generated a negative expected return over the last 90 days | |
| StemGen has some characteristics of a very speculative penny stock | |
| StemGen has high likelihood to experience some financial distress in the next 2 years | |
| StemGen currently holds 828.02 K in liabilities with Debt to Equity (D/E) ratio of 3.4, implying the company greatly relies on financing operations through barrowing. StemGen has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist StemGen until it has trouble settling it off, either with new capital or with free cash flow. So, StemGen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like StemGen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for StemGen to invest in growth at high rates of return. When we think about StemGen's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 39 K. Net Loss for the year was (433.14 K) with profit before overhead, payroll, taxes, and interest of 8.55 K. | |
| StemGen currently holds about 22.87 K in cash with (141.2 K) of positive cash flow from operations. | |
| Roughly 75.0% of StemGen outstanding shares are owned by corporate insiders |
StemGen Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of StemGen Pink Sheet often depends not only on the future outlook of the current and potential StemGen's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. StemGen's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 45.6 M | |
| Cash And Short Term Investments | 1343.00 |
StemGen Fundamentals Growth
StemGen Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of StemGen, and StemGen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on StemGen Pink Sheet performance.
| Return On Asset | -0.8 | |||
| Operating Margin | (20.01) % | |||
| Current Valuation | 5.11 M | |||
| Shares Outstanding | 45.67 M | |||
| Price To Earning | (11.53) X | |||
| Price To Sales | 228.36 X | |||
| Revenue | 39 K | |||
| EBITDA | (179.87 K) | |||
| Cash And Equivalents | 22.87 K | |||
| Total Debt | 828.02 K | |||
| Debt To Equity | 3.40 % | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (141.2 K) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 401.64 K | |||
| Retained Earnings | (1.61 M) | |||
| Current Asset | 1 K | |||
| Current Liabilities | 114 K | |||
About StemGen Performance
By evaluating StemGen's fundamental ratios, stakeholders can gain valuable insights into StemGen's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if StemGen has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if StemGen has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
StemGen, Inc. engages in the community offering and management of online competitions in the motorsports arena. The company offers a virtual to real platform in the motorsports industry. Stemgen operates under Electronic Gaming Multimedia classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about StemGen performance evaluation
Checking the ongoing alerts about StemGen for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for StemGen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| StemGen generated a negative expected return over the last 90 days | |
| StemGen has some characteristics of a very speculative penny stock | |
| StemGen has high likelihood to experience some financial distress in the next 2 years | |
| StemGen currently holds 828.02 K in liabilities with Debt to Equity (D/E) ratio of 3.4, implying the company greatly relies on financing operations through barrowing. StemGen has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist StemGen until it has trouble settling it off, either with new capital or with free cash flow. So, StemGen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like StemGen sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for StemGen to invest in growth at high rates of return. When we think about StemGen's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 39 K. Net Loss for the year was (433.14 K) with profit before overhead, payroll, taxes, and interest of 8.55 K. | |
| StemGen currently holds about 22.87 K in cash with (141.2 K) of positive cash flow from operations. | |
| Roughly 75.0% of StemGen outstanding shares are owned by corporate insiders |
- Analyzing StemGen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether StemGen's stock is overvalued or undervalued compared to its peers.
- Examining StemGen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating StemGen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of StemGen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of StemGen's pink sheet. These opinions can provide insight into StemGen's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for StemGen Pink Sheet analysis
When running StemGen's price analysis, check to measure StemGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy StemGen is operating at the current time. Most of StemGen's value examination focuses on studying past and present price action to predict the probability of StemGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move StemGen's price. Additionally, you may evaluate how the addition of StemGen to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Commodity Directory Find actively traded commodities issued by global exchanges |